GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genovis AB (FRA:5GV) » Definitions » Market Cap

Genovis AB (FRA:5GV) Market Cap : €111.82 Mil (As of Apr. 07, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Genovis AB Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Genovis AB's share price for the quarter that ended in Dec. 2024 was €2.07. Genovis AB's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 65.47 Mil. Therefore, Genovis AB's market cap for the quarter that ended in Dec. 2024 was €135.51 Mil.

Genovis AB's quarterly market cap declined from Jun. 2024 (€162.68 Mil) to Sep. 2024 (€158.76 Mil) and declined from Sep. 2024 (€158.76 Mil) to Dec. 2024 (€135.51 Mil).

Genovis AB's annual market cap increased from Dec. 2022 (€263.83 Mil) to Dec. 2023 (€313.91 Mil) but then declined from Dec. 2023 (€313.91 Mil) to Dec. 2024 (€135.51 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Genovis AB's Enterprise Value for Today is €107.76 Mil.


Genovis AB Market Cap Historical Data

The historical data trend for Genovis AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genovis AB Market Cap Chart

Genovis AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 185.27 471.36 263.83 313.91 135.51

Genovis AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 313.91 184.94 162.68 158.76 135.51

Competitive Comparison of Genovis AB's Market Cap

For the Biotechnology subindustry, Genovis AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genovis AB's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genovis AB's Market Cap distribution charts can be found below:

* The bar in red indicates where Genovis AB's Market Cap falls into.


;
;

Genovis AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Genovis AB's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=€2.07*65.466
=€135.51

Genovis AB's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=€2.07*65.466
=€135.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genovis AB  (FRA:5GV) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Genovis AB Market Cap Related Terms

Thank you for viewing the detailed overview of Genovis AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Genovis AB Business Description

Traded in Other Exchanges
Address
Scheelevagen 2, Box 790, Lund, SWE, SE-220 07
Genovis AB provides enzymes and technologies for the analytical characterization and conjugation of biopharmaceuticals. The principal activities of the company are to develop, produce, and market tools for developing new drugs and diagnostics. Its product line comprises GingisREX, FabRICATOR, GlyCLICK, GingisKHAN, GlycINATOR, Fabulous, lgGZERO, and Enzymes for O-glycan. The company's main product category consists of Enzymes and Antibodies. Geographically its segments include Sweden and the rest of the world.

Genovis AB Headlines

No Headlines